Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05111405

Study Comparing SBS and LRTI for Treatment of CMC Arthritis

A Randomized Prospective Multicenter Study Comparing Suture Button Suspensionplasty (SBS) with Ligament Reconstruction and Tendon Interposition (LRTI)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
138 (estimated)
Sponsor
Fraser Orthopaedic Research Society · Network
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

A multi-center, randomized control trial comparing the two standard of care surgical treatments for CMC arthritis ; trapezial excision with or without soft tissue interposition and /or ligament reconstruction (LRTI) versus the suture button suspension arthroplasty (SBS). Patient reported outcomes will be collected at 6 and 6 weeks, 3, 6, and 12 months.

Detailed description

LRTI is a well established treatment of CMC arthritis with good results.However, comparable results have also been reported with SBS, with the latter procedure eliminating the need for flexor carpi radialis (FCR) harvest and interposition, resulting in potential shorter OR time and donor site morbidity. To date, there have been biomechanical studies comparing LRTI vs suture button suspension arthroplasty (SBS), and clinical studies comparing trapeziectomy alone vs SBS, but to the best of our knowledge, no random control studies comparing LRTI with SBS.The primary objective is to determine whether treatment with SBS results in improved overall pain relief compared to LRTI as measured by patient reported outcomes.Secondary outcome measures will be to determine if SBS results in shorter OR time and improved grip and pinch strength compared to LRTI, as well as have comparable return to work times and amount of radiographic shortening as shown on radiographs (metacarpal shortening has been felt to lead to decreased grip strength).

Conditions

Interventions

TypeNameDescription
PROCEDURECMC ArthroplastySurgical intervention to treat CMC arthritis

Timeline

Start date
2022-06-20
Primary completion
2026-02-01
Completion
2026-05-01
First posted
2021-11-08
Last updated
2025-02-28

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05111405. Inclusion in this directory is not an endorsement.